6 Result(s)

Article

Correction to: Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study

Becky Pennington, Abualbishr Alshreef, Laura Flight, Andrew Metry… in PharmacoEconomics (2021)

Article

Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study

We aimed to assess the cost effectiveness of intravitreal ranibizumab (Lucentis), aflibercept (Eylea) and bevacizumab (Avastin) for the treatment of macular oedema due to central retinal vein occlusion.

Becky Pennington, Abualbishr Alshreef, Laura Flight, Andrew Metry… in PharmacoEconomics (2021)

Article

Increasing uptake of structured self-management education programmes for type 2 diabetes in a primary care setting: a feasibility study

Structured self-management education (SSME) for people with type 2 diabetes mellitus (T2DM) improves biomedical and psychological outcomes, whilst being cost-effective. Yet uptake in the UK remains low. An ‘Em...

Melanie Davies, Caroline A. Kristunas, Lisa Huddlestone… in Pilot and Feasibility Studies (2020)

Article

The impact of an intervention to increase uptake to structured self-management education for people with type 2 diabetes mellitus in primary care (the embedding package), compared to usual care, on glycaemic control: study protocol for a mixed methods study incorporating a wait-list cluster randomised controlled trial

Approximately 425 million people globally have diabetes, with ~ 90% of these having Type 2 Diabetes Mellitus (T2DM). This is a condition that leads to a poor quality of life and increased risk of serious healt...

Melanie J. Davies, Caroline A. Kristunas, Abualbishr Alshreef… in BMC Family Practice (2019)

Article

Cost-Effectiveness of Haemorrhoidal Artery Ligation versus Rubber Band Ligation for the Treatment of Grade II–III Haemorrhoids: Analysis Using Evidence from the HubBLe Trial

Haemorrhoids are a common condition, with nearly 30,000 procedures carried out in England in 2014/15, and result in a significant quality-of-life burden to patients and a financial burden to the healthcare sys...

Abualbishr Alshreef, Allan J. Wailoo, Steven R. Brown… in PharmacoEconomics - Open (2017)